| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $836.6M | +21.7% |
| Cost of Revenue | $63.7M | +0.3% |
| R&D Expense | $66.7M | -19.2% |
| SG&A Expense | $56.3M | -8.6% |
| Operating Income | $65.2M | +593.6% |
| Pre-tax Income | $68.2M | +1264.0% |
| Income Tax | $19.5M | +176.8% |
| Net Income | $48.7M | +60.2% |
| EPS (Basic) | $0.66 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.3M | +48.3% |
| Accounts Receivable | $111.0M | +8.6% |
| Current Assets | $244.7M | +24.4% |
| Total Assets | $461.1M | +5.4% |
| Current Liabilities | $70.9M | +18.0% |
| Total Liabilities | $86.6M | +18.0% |
| Stockholders' Equity | $374.5M | +2.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $131.6M | +83.3% |
| Capital Expenditures | $1.3M | +116.7% |
| Investing Cash Flow | -$33.3M | -12.1% |
| Financing Cash Flow | -$66.1M | +13.6% |
| Free Cash Flow | $130.3M | +83.0% |
| +65.0% |
| EPS (Diluted) | $0.64 | +68.4% |